SomaLogic, Inc.

Symbol: SLGCW

NASDAQ

0.086

USD

Market price today

  • -3.0131

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 396.23M

    MRK Cap

  • 0.00%

    DIV Yield

SomaLogic, Inc. (SLGCW) Financial Statements

On the chart you can see the default numbers in dynamics for SomaLogic, Inc. (SLGCW). Companys revenue shows the average of 66.842 M which is 0.279 % gowth. The average gross profit for the whole period is 29.552 M which is 0.695 %. The average gross profit ratio is 0.299 %. The net income growth for the company last year performance is 0.265 % which equals -0.145 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of SomaLogic, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.083. In the realm of current assets, SLGCW clocks in at 581.701 in the reporting currency. A significant portion of these assets, precisely 539.588, is held in cash and short-term investments. This segment shows a change of -0.180% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 0, if any, in the reporting currency. This indicates a difference of 0.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 0 in the reporting currency. This figure signifies a year_over_year change of 36.530%. Shareholder value, as depicted by the total shareholder equity, is valued at 562.558 in the reporting currency. The year over year change in this aspect is -0.081%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 17.006, with an inventory valuation of 13.9, and goodwill valued at 10.4, if any. The total intangible assets, if present, are valued at 16.7.

common:word.in-mln

USD
Growth
TTM2022202120202019

balance-sheet.row.cash-and-short-term-investments

1968.16539.6657.7204.9
45.6

balance-sheet.row.short-term-investments

447.7117.8218.240
31.5

balance-sheet.row.net-receivables

85.071717.117.4
4.2

balance-sheet.row.inventory

57.9513.911.27
8.4

balance-sheet.row.other-current-assets

24.69.95.11.2
1.6

balance-sheet.row.total-current-assets

2139.12581.7691.6232
59.8

balance-sheet.row.property-plant-equipment-net

76.1119.69.63.9
5.7

balance-sheet.row.goodwill

41.610.400
0

balance-sheet.row.intangible-assets

66.816.700
0

balance-sheet.row.goodwill-and-intangible-assets

108.427.100
0

balance-sheet.row.long-term-investments

0000
0

balance-sheet.row.tax-assets

0000
0

balance-sheet.row.other-non-current-assets

88.781956.4
-5.7

balance-sheet.row.total-non-current-assets

273.2965.714.610.3
5.7

balance-sheet.row.other-assets

0000
5.8

balance-sheet.row.total-assets

2412.41647.4706.1242.3
71.3

balance-sheet.row.account-payables

64.0116.815.17.1
3

balance-sheet.row.short-term-debt

24.232.50.12.4
0

balance-sheet.row.tax-payables

0000
0

balance-sheet.row.long-term-debt-total

2.760034.3
36.6

Deferred Revenue Non Current

125.3531.72.43.4
0

balance-sheet.row.deferred-tax-liabilities-non-current

1.06---
-

balance-sheet.row.other-current-liab

37.820.711.16.5
5.9

balance-sheet.row.total-non-current-liabilities

161.1641.564.838.6
36.6

balance-sheet.row.other-liabilities

0000
5.4

balance-sheet.row.capital-lease-obligations

5.242.50.10
0

balance-sheet.row.total-liab

302.6584.894.156.4
50.8

balance-sheet.row.preferred-stock

0000
0

balance-sheet.row.common-stock

0.08000
0.7

balance-sheet.row.retained-earnings

-2608.04-608.1-498.9-411.4
-358.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.67-0.5-0.10
0

balance-sheet.row.other-total-stockholders-equity

4718.41171.11111597.3
378

balance-sheet.row.total-stockholders-equity

2109.76562.6612185.9
20.4

balance-sheet.row.total-liabilities-and-stockholders-equity

2412.41647.4706.1242.3
0

balance-sheet.row.minority-interest

0000
0

balance-sheet.row.total-equity

2109.76562.6612185.9
20.4

balance-sheet.row.total-liabilities-and-total-equity

2412.41---
-

Total Investments

447.7117.8218.240
31.5

balance-sheet.row.total-debt

5.242.50.136.7
0

balance-sheet.row.net-debt

-1515.21-419.4-439.4-128.3
-14.1

Cash Flow Statement

The financial landscape of SomaLogic, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -1.423. The company recently extended its share capital by issuing 5.18, marking a difference of 5.556 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 2.34 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to 82542000.000 in the reporting currency. This is a shift of -1.445 from the previous year. In the same period, the company recorded 4.57, 0, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019

cash-flows.row.net-income

-130.38-109.2-87.5-53
-57

cash-flows.row.depreciation-and-amortization

7.224.62.62.8
3.2

cash-flows.row.deferred-income-tax

-2.83-0.811.613.1
-8.2

cash-flows.row.stock-based-compensation

24.0843.628.415.2
13.1

cash-flows.row.change-in-working-capital

-12.32285.7-8.7
-4.9

cash-flows.row.account-receivables

5.76-9.40.4-13.3
0.1

cash-flows.row.inventory

-3.51-3.7-30.5
-5

cash-flows.row.account-payables

-7.312.36.54
0

cash-flows.row.other-working-capital

-7.2738.81.80.1
0

cash-flows.row.other-non-cash-items

-11.14-66.92.32.3
3.3

cash-flows.row.net-cash-provided-by-operating-activities

-125.37000
0

cash-flows.row.investments-in-property-plant-an-equipment

3.48-5.2-6.7-1.2
-0.7

cash-flows.row.acquisitions-net

0.67-13.300
0

cash-flows.row.purchases-of-investments

-171.1-186.7-279.9-45.7
0

cash-flows.row.sales-maturities-of-investments

213.28287.7101.237.3
0

cash-flows.row.other-investing-activites

-0.67000.1
31.3

cash-flows.row.net-cash-used-for-investing-activites

45.6582.5-185.4-9.5
30.7

cash-flows.row.debt-repayment

00-36.50
0

cash-flows.row.common-stock-issued

5.185.2357.20
0

cash-flows.row.common-stock-repurchased

0000
0

cash-flows.row.dividends-paid

0000
0

cash-flows.row.other-financing-activites

-4.460176.8188.8
0.1

cash-flows.row.net-cash-used-provided-by-financing-activities

0.725.2497.5188.8
0.1

cash-flows.row.effect-of-forex-changes-on-cash

-0.04000
0

cash-flows.row.net-change-in-cash

-79.04-13275.1150.9
-19.7

cash-flows.row.cash-at-end-of-period

1529.43427.3440.3165.2
14.3

cash-flows.row.cash-at-beginning-of-period

1608.47440.3165.214.3
34.1

cash-flows.row.operating-cash-flow

-125.37-100.7-37-28.3
-50.5

cash-flows.row.capital-expenditure

3.48-5.2-6.7-1.2
-0.7

cash-flows.row.free-cash-flow

-121.89-105.9-43.7-29.5
-51.2

Income Statement Row

SomaLogic, Inc.'s revenue saw a change of 0.197% compared with the previous period. The gross profit of SLGCW is reported to be 54.3. The company's operating expenses are 230.06, showing a change of 89.404% from the last year. The expenses for depreciation and amortization are 4.57, which is a 34.773% change from the last accounting period. Operating expenses are reported to be 230.06, which shows a 89.404% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -1.398% year-over-year growth. The operating income is -175.76, which shows a 1.398% change when compared to the previous year. The change in the net income is 0.265%. The net income for the last year was -109.16.

common:word.in-mln

USD
Growth
TTM2022202120202019

income-statement-row.row.total-revenue

81.7297.781.655.9
32.2

income-statement-row.row.cost-of-revenue

48.0943.433.522.6
49.7

income-statement-row.row.gross-profit

33.6354.348.233.3
-17.5

income-statement-row.row.gross-profit-ratio

0000
0

income-statement-row.row.research-development

57.93---
-

income-statement-row.row.selling-general-administrative

34.26---
-

income-statement-row.row.selling-and-marketing-expenses

3.5---
-

income-statement-row.row.other-expenses

51.291.90.70
0

income-statement-row.row.operating-expenses

183.33230.1121.567.6
34

income-statement-row.row.cost-and-expenses

231.42273.4154.990.2
83.7

income-statement-row.row.interest-income

21.480.20.2
5.5

income-statement-row.row.interest-expense

-64.83-109.31.318.3
0

income-statement-row.row.selling-and-marketing-expenses

3.5---
-

income-statement-row.row.total-other-income-expensenet

7.8165.9-14.2-18.7
-6

income-statement-row.row.ebitda-ratio-caps

0---
-

income-statement-row.row.other-operating-expenses

51.291.90.70
0

income-statement-row.row.total-operating-expenses

7.8165.9-14.2-18.7
-6

income-statement-row.row.interest-expense

-64.83-109.31.318.3
0

income-statement-row.row.depreciation-and-amortization

7.3280.23.1
3.2

income-statement-row.row.ebitda-caps

-139.06---
-

income-statement-row.row.operating-income

-153.85-175.8-73.3-34.4
-51

income-statement-row.row.income-before-tax

-130-109.9-87.5-53
-57

income-statement-row.row.income-tax-expense

0.39-0.7-1.218.3
0

income-statement-row.row.net-income

-130.38-109.2-86.3-71.4
-57

Frequently Asked Question

What is SomaLogic, Inc. (SLGCW) total assets?

SomaLogic, Inc. (SLGCW) total assets is 647374000.000.

What is enterprise annual revenue?

The annual revenue is 42516000.000.

What is firm profit margin?

Firm profit margin is 0.412.

What is company free cash flow?

The free cash flow is -0.652.

What is enterprise net profit margin?

The net profit margin is -1.595.

What is firm total revenue?

The total revenue is -1.883.

What is SomaLogic, Inc. (SLGCW) net profit (net income)?

The net profit (net income) is -109157000.000.

What is firm total debt?

The total debt is 2477000.000.

What is operating expences number?

The operating expences are 230063000.000.

What is company cash figure?

Enretprise cash is 305571000.000.